| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 265,377 | 266,251 | 268,960 | 258,927 | | Cost of Revenue | 166,225 | 163,844 | 159,947 | 162,823 | | | Gross Profit | 99,152 | 102,407 | 109,013 | 96,104 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 59,118 | 58,881 | 57,936 | 52,834 | | Non Recurring | 7,889 | 6,935 | 6,296 | 323,766 | | Others | 25,756 | 26,185 | 26,201 | 28,674 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,389 | 10,406 | 18,580 | (309,170) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,775) | 13,017 | 133 | (6,203) | | Earnings Before Interest And Taxes | (2,386) | 23,423 | 18,713 | (315,373) | | Interest Expense | 18,696 | 16,074 | 16,678 | 18,334 | | Income Before Tax | (21,082) | 7,349 | 2,035 | (333,707) | | Income Tax Expense | 598 | 2,400 | 808 | (35,925) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (21,680) | 4,949 | 1,227 | (297,782) | | | Non-recurring Events | | Discontinued Operations | (241) | (241) | (296) | 85 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,921) | 4,708 | 931 | (297,697) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($21,921) | $4,708 | $931 | ($297,697) |
|
0.51% Nasdaq 
Income Statement
